AstraZeneca plc (AZN) Ordinary US$0.25
6.00p
(0.11%)
- Add to watchlist
- Create an alert
- This stock can be held in a
6.00p
(0.11%)
6.00p
(0.11%)
5,636.00p
5,739.33p
6,432.00p
£71.52 bn
5,640.00p
5,615.03p
4,544.50p
16.99
70.00p (1.26%) Previous:
70.00p
160,440
3.59%
300
Performance
| 1 week 1W | 2.38% | 1 year 1Y | 11.84% |
|---|---|---|---|
| 1 month 1M | 5.15% | 2 years 2Y | 26.22% |
| 3 months 3M | 4.91% | 3 years 3Y | 32.04% |
| 6 months 6M | 1.38% | 5 years 5Y | 42.89% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2017 | 31/12/2016 |
|---|---|---|
| Revenue ($m) | 20,152.00 | 21,319.00 |
| Profit before tax ($m) | 2,227.00 | 3,552.00 |
| Adjusted EPS (¢): | 428.00 | 431.00 |
| P/E ratio | 15.40 | 13.30 |
| PEG | n/a | 13.30 |
| EPS growth (%) | (1.00) | 1.00 |
Values are quoted in the stock's local currency: US dollar
All fundamental dataRecent dividends paid or declared by AstraZeneca plc:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| 2nd interim * | 28/02/2019 | 27/03/2019 | 190.00¢ |
| 1st interim | 09/08/2018 | 10/09/2018 | 90.00¢ |
| 2nd interim | 15/02/2018 | 19/03/2018 | 190.00¢ |
| 1st interim | 10/08/2017 | 11/09/2017 | 90.00¢ |
| 2nd interim | 16/02/2017 | 20/03/2017 | 190.00¢ |
* Dividend has not yet been paid but has been declared by AstraZeneca plc.
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual AstraZeneca plc dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2017 | 4.20% | 1.53 | $2.80 |
| 31/12/2016 | 4.90% | 1.54 | $2.80 |
| 31/12/2015 | 4.70% | 1.52 | $2.80 |
| 31/12/2014 | 4.80% | 1.53 | $2.80 |
| 31/12/2013 | 6.10% | 1.80 | $2.80 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyOpen an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 13) -
Sell
(0 of 13) -
Neutral
(7 of 13) -
Buy
(1 of 13) -
Strong Buy
(5 of 13)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
AstraZeneca offloads rights to Nexium and Vimovo
3 December 2018 07:25
-
US FDA grants orphan status for AstraZeneca's Fasenra
26 November 2018 07:18
-
Monday broker round-up
19 November 2018 12:13
-
Total Voting Rights
3 December 2018 16:00
-
Block listing Interim Review
3 December 2018 16:00
-
Grünenthal Agreement for Nexium, Vimovo Completed
3 December 2018 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.